Home > News > New drug Lapatinib shrinks breast cancer
April 17th, 2008
New drug Lapatinib shrinks breast cancer
Abstract:
Microscopic magnets could be used to guide modified human cells to attack tumours, according to research (Mark Henderson writes).
The technique, which combines nanotechnology and gene therapy, could help specially "armed" human immune cells to home in on cancer cells to destroy them. A team led by Professor Claire Lewis, at Sheffield University, developed a procedure that involves inserting nanomagnets into a type of white blood cell. When a magnet is placed over a tumour, the cells move towards it and attack. Details are published in the journal Gene Therapy.
Source:
timesonline.co.uk
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Nanomedicine
3-D printing could lead to tiny medical implants, electronics, robots, more June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013